Synairgen (SNG) respiratory drug discovery company based in Southampton - Reports data from the at-home cohort in SG016 Phase II trial of SNG001 drug in Covid-19. "The vast majority of home cohort patients experienced mild disease - only two patients were hospitalised during the treatment period, both on placebo." The data reinforces the company's confi…
© 2024 📈 🐝 Small Company Champion
Substack is the home for great culture